Clinical trial

Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC

NCT07467863

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-02-02

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2026-02-02Date precision: day

Registry last updated2026-03-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

Advanced/Metastatic NSCLCunresolved

Interventions

Dual-target CAR-NK cellsBIOLOGICAL

Lymphodepleting chemotherapyDRUG

Supportive CareOTHER

Sponsors & collaborators

Beijing Biotechlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07467863 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.